Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

0.00%

3.9¢ g medical innovations holdings limited

Ann: CE, FDA and CFDA Approval - Guangzhou Production Facility, page-167

First 167 Last

Share
Profile

Follow
HonyakuKonyaku

662 Posts.

332

01/11/18

08:03

Post #: 36344044
Share

Originally posted by razi: ↑

True that we anxiously waited (for what seemed like an eternity) for CFDA & exhaled mightily when it seemed to arrive. And, yes, probably most of us were disappointed that the SP rose "only" 10% when trading resumed (I certainly was, having seen that it opened at 0.45 upon going to sleep & then seeing a green 0.375 upon awakening...which almost had a reddish tint to it). That said, it's apt to be a long & winding road ahead...requiring considerable patience & continued belief in the essential nature/vision of the what GMV strives to offer. Unlike the recreational/faddish "toys" VR & Kinect, the Prizma/Patch & call centers address a clear universal health need that could/should appeal to almost anyone, anywhere. CFDA was never the end game...just a MAJOR obstacle along the way that needed to be overcome. And now that the path has been cleared, generating revenue will have to follow if the venture is to succeed. That could take MANY months to happen (or perhaps never). Big-agenda startups, like ours, typically need more time than others to unfold...but things DO seem to be progressing in the right direction -- even if more slowly than what most of us would prefer. If long-term, like me, I suggest trying to chill, appreciating the not inconsequential progress already made, retaining faith in the concept/products/services & in Dr. Geva's knowing how to get the job done. Best wishes to all...

Expand

Thanks for the measured replies. I was probably a bit out of line with my post. Nasdaq had a good session so maybe there will be a bit more appetite for risk today.

GMV Price at posting: 37.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: ASX200 to rise for Friday session | July 26

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement